Related Experiment Video
Updated: Apr 12, 2026

Trypsin Digest Protocol to Analyze the Retinal Vasculature of a Mouse Model
Published on: June 13, 2013
Molecular mechanisms of diabetic retinopathy: potential therapeutic targets
Maha Coucha1, Sally L Elshaer1, Wael S Eldahshan1
1Department of Clinical Pharmacy, Program in Clinical and Experimental Therapeutics, University of Georgia, Georgia, USA ; Culver Vision Discovery Institute, Georgia Regents University, Georgia, USA ; Research Service, Charlie Norwood VA Medical Center, Augusta 30912, Georgia, USA.
Abstract:
Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults in United States. Research indicates an association between oxidative stress and the development of diabetes complications. However, clinical trials with general antioxidants have failed to prove effective in diabetic patients. Mounting evidence from experimental studies that continue to elucidate the damaging effects of oxidative stress and inflammation in both vascular and neural retina suggest its critical role in the pathogenesis of DR. This review will outline the current management of DR as well as present potential experimental therapeutic interventions, focusing on molecules that link oxidative stress to inflammation to provide potential therapeutic targets for treatment or prevention of DR. Understanding the biochemical changes and the molecular events under diabetic conditions could provide new effective therapeutic tools to combat the disease.
Insights
Diabetic retinopathy (DR) causes blindness in working adults. This review explores how oxidative stress and inflammation contribute to DR, identifying potential therapeutic targets for prevention and treatment.
Area of Science:
- Ophthalmology
- Endocrinology
- Molecular Biology
Background:
- Diabetic retinopathy (DR) is a leading cause of vision loss in the working-age population.
- Oxidative stress is linked to diabetes complications, but general antioxidant trials have been ineffective.
- Emerging evidence highlights the critical role of oxidative stress and inflammation in DR pathogenesis.
Purpose of the Study:
- To review current diabetic retinopathy management strategies.
- To present experimental therapeutic interventions for DR.
- To identify molecular targets linking oxidative stress and inflammation for DR treatment.
Main Methods:
- Literature review of experimental studies on DR.
- Analysis of molecular mechanisms involving oxidative stress and inflammation.
- Evaluation of potential therapeutic targets for DR.
Main Results:
- Oxidative stress and inflammation are key players in the development of diabetic retinopathy.
- Specific molecular pathways linking these processes offer potential therapeutic avenues.
- Current management strategies and experimental interventions are discussed.
Conclusions:
- Targeting the interplay between oxidative stress and inflammation holds promise for novel DR therapies.
- Understanding biochemical and molecular changes in diabetes is crucial for developing effective treatments.
- Further research into these molecular links could lead to new tools to combat diabetic retinopathy.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

